CA Stock MarketDetailed Quotes

VM Voyageur Pharmaceuticals Ltd

Watchlist
  • 0.050
  • -0.010-16.67%
15min DelayMarket Closed Sep 27 16:00 ET
6.97MMarket Cap-5000P/E (TTM)

Voyageur Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
(Q3)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
60.49%-189.29K
61.39%-183.07K
42.33%-991.25K
116.21%29.56K
93.86%-67.48K
-323.22%-479.13K
-46.31%-474.2K
-4.27%-1.72M
60.29%-182.39K
-272.47%-1.1M
Net income from continuing operations
9.51%-562.4K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
71.48%-121.96K
-23.28%-621.49K
-51.08%-373.69K
14.51%-1.75M
-11.00%-574.78K
61.87%-427.63K
Operating gains losses
--6.11K
--1.25K
-119.92%-1.24K
---17.59K
--0
----
----
--6.21K
----
----
Depreciation and amortization
-28.21%392
-28.02%393
-76.28%2.19K
-92.23%546
-24.76%547
-24.90%546
-24.90%546
11.98%9.21K
-14.54%7.03K
--727
Asset impairment expenditure
----
----
--48.61K
----
----
----
----
--0
----
----
Remuneration paid in stock
7.80%239.55K
367.25%125.07K
12.90%234.03K
-87.39%12.22K
-124.60%-27.16K
--222.21K
--26.77K
-71.90%207.29K
589.95%96.89K
--110.4K
Other non cashItems
----
---1
-74.21%14.48K
--14.48K
----
----
----
--56.15K
----
----
Change In working capital
231.33%127.05K
114.99%19.17K
145.19%110.15K
12.17%253.63K
110.36%81.09K
-124.79%-96.75K
-64.97%-127.82K
28.87%-243.73K
222.55%226.11K
-1,234.55%-782.56K
-Change in receivables
-43.12%-9.16K
228.36%18.08K
-168.26%-12.05K
-1,108.36%-9.29K
-44.27%17.72K
26.13%-6.4K
-120.13%-14.08K
161.14%17.65K
111.01%921
803.21%31.79K
-Change in inventory
--0
--0
--0
----
----
--0
--0
-463.10%-610
----
----
-Change in prepaid assets
-4.55%46.33K
-4,816.94%-131.18K
174.84%51.12K
-60.24%16.9K
90.13%-11.65K
5,004.21%48.54K
-142.46%-2.67K
-195.72%-68.31K
187.49%42.5K
-315.13%-118.04K
-Change in payables and accrued expense
164.71%89.88K
219.09%132.27K
136.93%71.08K
34.21%246.02K
110.77%75.02K
-134.90%-138.89K
-43.56%-111.07K
33.83%-192.46K
187.29%183.3K
-3,757.45%-696.31K
Cash from discontinued investing activities
Operating cash flow
60.49%-189.29K
61.39%-183.07K
42.33%-991.25K
116.21%29.56K
93.86%-67.48K
-323.22%-479.13K
-46.31%-474.2K
-4.27%-1.72M
60.29%-182.39K
-272.47%-1.1M
Investing cash flow
Cash flow from continuing investing activities
15.05%-38.1K
10.44%-37.55K
36.27%-174.72K
11.66%-33.21K
15.65%-54.74K
-291.95%-44.85K
78.51%-41.92K
37.42%-274.15K
79.73%-37.59K
46.48%-64.89K
Capital expenditure reported
----
----
----
----
----
----
----
----
----
---231.61K
Net PPE purchase and sale
----
----
--0
--0
----
----
----
--8.76K
--11.24K
----
Net other investing changes
15.05%-38.1K
10.44%-37.55K
38.24%-174.72K
----
----
-291.95%-44.85K
78.23%-41.92K
35.42%-282.91K
----
----
Cash from discontinued investing activities
Investing cash flow
15.05%-38.1K
10.44%-37.55K
36.27%-174.72K
11.66%-33.21K
15.65%-54.74K
-291.95%-44.85K
78.51%-41.92K
37.42%-274.15K
79.73%-37.59K
46.48%-64.89K
Financing cash flow
Cash flow from continuing financing activities
-138.59%-9.19K
-58.80%468.28K
-6.19%1.14M
129.61%3.85K
0
-145.79%-3.85K
3,760.51%1.14M
-58.17%1.21M
-39.06%-13.01K
514.68%1.19M
Net issuance payments of debt
----
----
--0
--0
----
----
----
12.18%-16.56K
6.29%-8.76K
-148.90%-4.64K
Net common stock issuance
-46.30%-5.63K
-58.86%493.6K
-3.70%1.2M
190.80%3.85K
--0
---3.85K
--1.2M
-45.94%1.25M
---4.24K
--1.25M
Proceeds from stock option exercised by employees
----
----
--0
----
----
----
----
-94.78%41K
--0
--0
Net other financing activities
---3.56K
60.09%-25.32K
-7.54%-63.45K
--0
--0
--0
---63.45K
66.47%-59K
--0
----
Cash from discontinued financing activities
Financing cash flow
-138.61%-9.19K
-58.80%468.28K
-6.19%1.14M
129.61%3.85K
--0
-145.79%-3.85K
3,760.51%1.14M
-58.17%1.21M
-39.08%-13.01K
514.68%1.19M
Net cash flow
Beginning cash position
-61.69%249.75K
-93.39%2.09K
-96.12%31.56K
-99.29%1.88K
-48.68%124.1K
101.67%651.94K
-96.12%31.56K
27,300.30%812.97K
-81.97%264.54K
-85.69%241.83K
Current changes in cash
55.18%-236.58K
-60.08%247.67K
96.23%-29.48K
100.09%203
-638.30%-122.22K
-548.18%-527.83K
226.68%620.37K
-196.47%-781.41K
64.38%-232.98K
110.17%22.71K
End cash Position
-89.39%13.17K
-61.69%249.75K
-93.39%2.09K
-93.39%2.09K
-99.29%1.88K
-48.68%124.1K
101.67%651.94K
-96.12%31.56K
-96.12%31.56K
-81.97%264.54K
Free cash from
60.49%-189.29K
61.39%-183.07K
42.33%-991.25K
215.76%171.07K
84.32%-209K
-323.22%-479.13K
-45.20%-474.2K
-4.27%-1.72M
111.80%54.18K
-374.49%-1.33M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022(Q3)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 60.49%-189.29K61.39%-183.07K42.33%-991.25K116.21%29.56K93.86%-67.48K-323.22%-479.13K-46.31%-474.2K-4.27%-1.72M60.29%-182.39K-272.47%-1.1M
Net income from continuing operations 9.51%-562.4K11.97%-328.95K20.21%-1.4M50.88%-282.33K71.48%-121.96K-23.28%-621.49K-51.08%-373.69K14.51%-1.75M-11.00%-574.78K61.87%-427.63K
Operating gains losses --6.11K--1.25K-119.92%-1.24K---17.59K--0----------6.21K--------
Depreciation and amortization -28.21%392-28.02%393-76.28%2.19K-92.23%546-24.76%547-24.90%546-24.90%54611.98%9.21K-14.54%7.03K--727
Asset impairment expenditure ----------48.61K------------------0--------
Remuneration paid in stock 7.80%239.55K367.25%125.07K12.90%234.03K-87.39%12.22K-124.60%-27.16K--222.21K--26.77K-71.90%207.29K589.95%96.89K--110.4K
Other non cashItems -------1-74.21%14.48K--14.48K--------------56.15K--------
Change In working capital 231.33%127.05K114.99%19.17K145.19%110.15K12.17%253.63K110.36%81.09K-124.79%-96.75K-64.97%-127.82K28.87%-243.73K222.55%226.11K-1,234.55%-782.56K
-Change in receivables -43.12%-9.16K228.36%18.08K-168.26%-12.05K-1,108.36%-9.29K-44.27%17.72K26.13%-6.4K-120.13%-14.08K161.14%17.65K111.01%921803.21%31.79K
-Change in inventory --0--0--0----------0--0-463.10%-610--------
-Change in prepaid assets -4.55%46.33K-4,816.94%-131.18K174.84%51.12K-60.24%16.9K90.13%-11.65K5,004.21%48.54K-142.46%-2.67K-195.72%-68.31K187.49%42.5K-315.13%-118.04K
-Change in payables and accrued expense 164.71%89.88K219.09%132.27K136.93%71.08K34.21%246.02K110.77%75.02K-134.90%-138.89K-43.56%-111.07K33.83%-192.46K187.29%183.3K-3,757.45%-696.31K
Cash from discontinued investing activities
Operating cash flow 60.49%-189.29K61.39%-183.07K42.33%-991.25K116.21%29.56K93.86%-67.48K-323.22%-479.13K-46.31%-474.2K-4.27%-1.72M60.29%-182.39K-272.47%-1.1M
Investing cash flow
Cash flow from continuing investing activities 15.05%-38.1K10.44%-37.55K36.27%-174.72K11.66%-33.21K15.65%-54.74K-291.95%-44.85K78.51%-41.92K37.42%-274.15K79.73%-37.59K46.48%-64.89K
Capital expenditure reported ---------------------------------------231.61K
Net PPE purchase and sale ----------0--0--------------8.76K--11.24K----
Net other investing changes 15.05%-38.1K10.44%-37.55K38.24%-174.72K---------291.95%-44.85K78.23%-41.92K35.42%-282.91K--------
Cash from discontinued investing activities
Investing cash flow 15.05%-38.1K10.44%-37.55K36.27%-174.72K11.66%-33.21K15.65%-54.74K-291.95%-44.85K78.51%-41.92K37.42%-274.15K79.73%-37.59K46.48%-64.89K
Financing cash flow
Cash flow from continuing financing activities -138.59%-9.19K-58.80%468.28K-6.19%1.14M129.61%3.85K0-145.79%-3.85K3,760.51%1.14M-58.17%1.21M-39.06%-13.01K514.68%1.19M
Net issuance payments of debt ----------0--0------------12.18%-16.56K6.29%-8.76K-148.90%-4.64K
Net common stock issuance -46.30%-5.63K-58.86%493.6K-3.70%1.2M190.80%3.85K--0---3.85K--1.2M-45.94%1.25M---4.24K--1.25M
Proceeds from stock option exercised by employees ----------0-----------------94.78%41K--0--0
Net other financing activities ---3.56K60.09%-25.32K-7.54%-63.45K--0--0--0---63.45K66.47%-59K--0----
Cash from discontinued financing activities
Financing cash flow -138.61%-9.19K-58.80%468.28K-6.19%1.14M129.61%3.85K--0-145.79%-3.85K3,760.51%1.14M-58.17%1.21M-39.08%-13.01K514.68%1.19M
Net cash flow
Beginning cash position -61.69%249.75K-93.39%2.09K-96.12%31.56K-99.29%1.88K-48.68%124.1K101.67%651.94K-96.12%31.56K27,300.30%812.97K-81.97%264.54K-85.69%241.83K
Current changes in cash 55.18%-236.58K-60.08%247.67K96.23%-29.48K100.09%203-638.30%-122.22K-548.18%-527.83K226.68%620.37K-196.47%-781.41K64.38%-232.98K110.17%22.71K
End cash Position -89.39%13.17K-61.69%249.75K-93.39%2.09K-93.39%2.09K-99.29%1.88K-48.68%124.1K101.67%651.94K-96.12%31.56K-96.12%31.56K-81.97%264.54K
Free cash from 60.49%-189.29K61.39%-183.07K42.33%-991.25K215.76%171.07K84.32%-209K-323.22%-479.13K-45.20%-474.2K-4.27%-1.72M111.80%54.18K-374.49%-1.33M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data